Evidence map›Paper›PMID 31556486›Full record

ArticleMolecular systems biology2019

An integrated workflow for crosslinking mass spectrometry.

Marta L Mendes, Lutz Fischer, Zhuo A Chen, Marta Barbon, Francis J O'Reilly, Sven H Giese, Michael Bohlke-Schneider, Adam Belsom, Therese Dau, Colin W Combe and 5 more

Open access · goldAbstract read
In one paragraph

Article in Molecular systems biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 231 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Marta L MendesBioanalytics, Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany.ORCID 0000-0002-3528-7123
Lutz FischerBioanalytics, Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany.ORCID 0000-0003-4978-0864
Zhuo A ChenBioanalytics, Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany.
Marta BarbonMRC London Institute of Medical Sciences (LMS), London, UK.ORCID 0000-0003-0891-5507
Francis J O'ReillyBioanalytics, Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany.ORCID 0000-0001-9258-0150
Sven H GieseBioanalytics, Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany.
Michael Bohlke-SchneiderBioanalytics, Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany.
Adam BelsomBioanalytics, Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany.
Therese DauWellcome Centre for Cell Biology, University of Edinburgh, Edinburgh, UK.
Colin W CombeWellcome Centre for Cell Biology, University of Edinburgh, Edinburgh, UK.
Martin GrahamWellcome Centre for Cell Biology, University of Edinburgh, Edinburgh, UK.
Markus R EiseleDepartment of Molecular Structural Biology, Max Planck Institute of Biochemistry, Martinsried, Germany.
Wolfgang BaumeisterDepartment of Molecular Structural Biology, Max Planck Institute of Biochemistry, Martinsried, Germany.
Christian SpeckMRC London Institute of Medical Sciences (LMS), London, UK.
Juri RappsilberBioanalytics, Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany.ORCID 0000-0001-5999-1310
Wellcome Centre for Cell Biology · GBTechnische Universität Berlin · DEMax Planck Institute of Biochemistry · DEMRC London Institute of Medical Sciences · GB

Funding

Medical Research Council MC_U120085811UK Research and Innovation | Biotechnology and Biological Sciences Research Council (BBSRC) BB/N000323/1UK Research and Innovation | Medical Research Council (MRC) MC_U120085811Wellcome Trust 103139Wellcome Trust 103139/Z/13/ZWellcome Trust 108504Wellcome Trust 203149Wellcome Trust (WT) 107903/Z/15/Z
6 · The paper itself

Abstract

We present a concise workflow to enhance the mass spectrometric detection of crosslinked peptides by introducing sequential digestion and the crosslink identification software xiSEARCH. Sequential digestion enhances peptide detection by selective shortening of long tryptic peptides. We demonstrate our simple 12-fraction protocol for crosslinked multi-protein complexes and cell lysates, quantitative analysis, and high-density crosslinking, without requiring specific crosslinker features. This overall approach reveals dynamic protein-protein interaction sites, which are accessible, have fundamental functional relevance and are therefore ideally suited for the development of small molecule inhibitors.

Indexed as

CytosolHumansK562 CellsMass SpectrometryModels, MolecularPeptide FragmentsProtein ConformationProtein Interaction MappingProteinsProteomicsSoftwarePeptide FragmentsProteinscrosslinking mass spectrometryprotein-protein interactionsproteomicssoftwarestructural biology

Identifiers

PMID31556486
PMCPMC6753376
OpenAlexW2974834003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.